THAROS™ is a research-led equine health and performance company focusing on the digestive health, the gut microbiome and colonic malfermentation. THAROS™ are committed to the promotion of equine health and increased wellbeing through leading edge research, discovery and innovation. We harness the potential of both science and nature. Following four years of groundbreaking research with Cumani Racing and others we have developed a pioneering digestive product, EQUINECTAR ® . Diet and digestion are key issues for performance horses and their management, THAROS™ presents a compelling opportunity to horse professionals worldwide. THAROS™ is a member of the British Equestrian Trade Association (BETA).